Janet McNicholas

180-Day Notice Of Commercial Marketing Mandatory Even When Biosimilar Applicants Do The "Patent Dance"

USPTO Sends Guidance On Subject Matter Eligibility In View Of Enfish Decision

U.S. Patent Office Releases "May 2016 Subject Matter Eligibility Update"

FDA Indicates Shared Nonproprietary Names Not Appropriate for All Biological Products, Including Biosimilars